Any person may file a new animal drug application (NADA) seeking FDA approval to legally market a new animal drug. The application must include safety and effectiveness data, proposed labeling, product manufacturing information, and where necessary, complete information on food safety (including microbial food safety) and any methods used to determine residues of drug in edible tissue from food producing animals. FDA Guidance #152 outlines a risk assessment approach for evaluating the microbial food safety of antimicrobial new animal drugs. We request that applicants utilize Form FDA 356V, as appropriate, to ensure efficient and accurate processing of information to support new animal drug approval. Respondents may choose to use veterinary master files to provide and organize confidential detailed information to the Agency. Veterinary master files can be used as repositories for information that can be referenced in multiple submissions to the Agency, thus minimizing paperwork burden.
Based on a review of the information collection since our last request for OMB approval, we have made the following adjustments:
In previous submissions of this ICR we included the time necessary to compile and submit information to veterinary master files within the burden estimates provided for applications and amended applications (for NADAs and INAD files). In this request for OMB extension of approval, we anticipate respondentsâ need for increased use of veterinary master files and therefore seek approval for such increase. We have separately estimated the burden of the âUse of veterinary master files during all phases of product development (including product development that precedes the establishment of an INAD file or the submission of an NADA)â in table 1, row 10.
We report an additional 300 burden hours and 15 total annual responses in row 10, representing such increased use of veterinary master files. In addition, we are also correcting several rounding errors that were made in our last request for OMB approval. Thus, our estimated burden for the information collection reflects a net overall increase of 124 hours and a corresponding increase of 14 responses.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.